BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25971527)

  • 1. miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor.
    Shen X; Guo Y; Yu J; Qi J; Shi W; Wu X; Ni H; Ju S
    Clin Exp Med; 2016 Aug; 16(3):307-16. PubMed ID: 25971527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of miR-202 on the growth of multiple myeloma cells via regulating B cell-activating factor and the underlying mechanism].
    Yu JJ; Shen XJ; Wang XD; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):886-91. PubMed ID: 24506956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells.
    Shen X; Guo Y; Qi J; Shi W; Wu X; Ni H; Ju S
    Pathol Oncol Res; 2016 Jul; 22(3):531-9. PubMed ID: 26689580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation.
    Wang X; Li C; Ju S; Wang Y; Wang H; Zhong R
    Leuk Lymphoma; 2011 Oct; 52(10):1991-8. PubMed ID: 21718132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
    Pitari MR; Rossi M; Amodio N; Botta C; Morelli E; Federico C; Gullà A; Caracciolo D; Di Martino MT; Arbitrio M; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2015 Sep; 6(29):27343-58. PubMed ID: 26160841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-145 Regulates Diabetes-Bone Marrow Stromal Cell-Induced Neurorestorative Effects in Diabetes Stroke Rats.
    Cui C; Ye X; Chopp M; Venkat P; Zacharek A; Yan T; Ning R; Yu P; Cui G; Chen J
    Stem Cells Transl Med; 2016 Dec; 5(12):1656-1667. PubMed ID: 27460851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Expression Profile of Neural Progenitor-Like Cells Derived from Rat Bone Marrow Mesenchymal Stem Cells under the Influence of IGF-1, bFGF and EGF.
    Huat TJ; Khan AA; Abdullah JM; Idris FM; Jaafar H
    Int J Mol Sci; 2015 Apr; 16(5):9693-718. PubMed ID: 25938966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis.
    Lwin T; Crespo LA; Wu A; Dessureault S; Shu HB; Moscinski LC; Sotomayor E; Dalton WS; Tao J
    Leukemia; 2009 Jan; 23(1):170-7. PubMed ID: 18843286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of miRNA-15a/-16 expression on the drug resistance of myeloma cells].
    Zang MR; Li F; An G; Xie ZQ; Li CH; Yu Z; Xu Y; Qiu LG; Hao M
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1100-3. PubMed ID: 22781767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.
    Chauhan D; Uchiyama H; Akbarali Y; Urashima M; Yamamoto K; Libermann TA; Anderson KC
    Blood; 1996 Feb; 87(3):1104-12. PubMed ID: 8562936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
    Gupta N; Kumar R; Seth T; Garg B; Sharma A
    RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
    Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
    Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BAFF level in bone marrow and expression of BAFF receptor on B cells in multiple myeloma patients].
    Zhou ZH; Zhang L; Pan QY; Huang BH; Zheng D; Liu JR; Li J; Luo SK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1131-4. PubMed ID: 23114133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of B-cell maturation antigen to B-cell activating factor induces survival of multiple myeloma cells by activating Akt and JNK signaling pathways.
    Shen X; Guo Y; Qi J; Shi W; Wu X; Ju S
    Cell Biochem Funct; 2016 Mar; 34(2):104-10. PubMed ID: 26914861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
    Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
    J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of a tumor microenvironment-mediated P65-miR-30a-5p-BCL2L11 amplification loop in multiple myeloma.
    Xie L; Wei J; Gao Z; Huang H; Ju S; Wang X
    Exp Cell Res; 2022 Jun; 415(1):113113. PubMed ID: 35339472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43.
    Jin J; Wang T; Wang Y; Chen S; Li Z; Li X; Zhang J; Wang J
    Int J Oncol; 2017 Dec; 51(6):1694-1704. PubMed ID: 29075794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
    Berenstein R; Blau O; Nogai A; Waechter M; Slonova E; Schmidt-Hieber M; Kunitz A; Pezzutto A; Doerken B; Blau IW
    BMC Cancer; 2015 Feb; 15():68. PubMed ID: 25886144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of B cell-activating factor of TNF family (BAFF) and B cell lymphoma/leukemia-2 (BCL-2) in multiple myeloma].
    Wang SM; Zhang TL; Jiang YM; Wu HY; Hao LM; Xing XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):395-8. PubMed ID: 21518495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.